ATE185548T1 - Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress - Google Patents

Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress

Info

Publication number
ATE185548T1
ATE185548T1 AT94900187T AT94900187T ATE185548T1 AT E185548 T1 ATE185548 T1 AT E185548T1 AT 94900187 T AT94900187 T AT 94900187T AT 94900187 T AT94900187 T AT 94900187T AT E185548 T1 ATE185548 T1 AT E185548T1
Authority
AT
Austria
Prior art keywords
arylmethylene
ethylenediamine diacetate
diarylmethylene
iminodiacetate
oxidative stress
Prior art date
Application number
AT94900187T
Other languages
English (en)
Inventor
Jean-Baptiste Galey
Jacqueline Dumats
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9213707A external-priority patent/FR2698095B1/fr
Priority claimed from FR9307641A external-priority patent/FR2706889A1/fr
Application filed by Oreal filed Critical Oreal
Application granted granted Critical
Publication of ATE185548T1 publication Critical patent/ATE185548T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/16—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
AT94900187T 1992-11-13 1993-11-10 Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress ATE185548T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9213707A FR2698095B1 (fr) 1992-11-13 1992-11-13 Utilisation de composés dibenzyléthylène diamino diacétate contre le stress oxydant, compositions pharmaceutiques ou cosmétiques les contenant, composés nouveaux et leur procédé de préparation.
FR9307641A FR2706889A1 (en) 1993-06-23 1993-06-23 Use of N-(arylmethylene)ethylenediaminetriacetate, N-(arylmethylene)iminodiacetate or N,N'-di(arylmethylene)ethylenediaminediacetate compounds against oxidative stress

Publications (1)

Publication Number Publication Date
ATE185548T1 true ATE185548T1 (de) 1999-10-15

Family

ID=26229869

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94900187T ATE185548T1 (de) 1992-11-13 1993-11-10 Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress

Country Status (8)

Country Link
US (2) US5703095A (de)
EP (1) EP0668854B1 (de)
JP (1) JP3510627B2 (de)
AT (1) ATE185548T1 (de)
CA (1) CA2149431A1 (de)
DE (1) DE69326776T2 (de)
ES (1) ES2136723T3 (de)
WO (1) WO1994011338A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2728258A1 (fr) * 1994-12-19 1996-06-21 Oreal Utilisation d'un derive de l'ethylene diamine dans une composition cosmetique ou dermatologique et composition contenant notamment un produit a effet secondaire irritant
FR2737205B1 (fr) 1995-07-26 1997-09-12 Oreal Nouveaux derives de n,n'-di(aralkyl) n,n'-di(2-azaaralkyl) alkylene diamine et leur utilisation dans des compositions pharmaceutiques et cosmetiques
FR2737204B1 (fr) * 1995-07-26 1997-09-12 Oreal Derives de n,n'-di(aralkyl)n,n'-di(carboxylakyl)alkylene di- ou triamine et de n-(aralkyl)n'-(carboxyalkyl) n,n'-di(carboxyalkyl)alkylene di- ou triamine et leur utilisation en pharmacie et en cosmetique
FR2749845B1 (fr) * 1996-06-18 1998-08-21 Oreal Nouveaux derives benzyl substitue(s) de polyalkylene-polyamines et leur utilisation dans des compositions cosmetiques et pharmaceutiques
FR2751538B1 (fr) * 1996-07-26 1998-09-11 Oreal Utilisation de derives de l'acide n,n'-dibenzyl ethylenediamine n,n'-diacetique comme agents depigmentants
US6005006A (en) * 1996-07-26 1999-12-21 L'oreal Use of N,N'-dibenzylethylenediamine-N,N'-diacetic acid derivatives as depigmenting agents
FR2768145B1 (fr) * 1997-09-09 1999-10-08 Oreal Nouveaux composes derives d'acide alkylene diamine di- ou tri-acetique, leur procede de preparation, leur utilisation dans des compositions cosmetiques et pharmaceutiques, et compositions les comprenant
DE69919707T2 (de) 1998-06-19 2005-09-01 Chiron Corp., Emeryville Glycogen synthase kinase 3 inhibitoren
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
FR2809002B1 (fr) * 2000-05-18 2003-01-24 Oreal Utilisation de derives de l'acide n,n'-dibenzyl ethylene diamine n,n'-diacetique comme agent anti-pollution
FR2809003B1 (fr) * 2000-05-18 2003-01-24 Oreal Compositions anti-pollution a base d'anthocyanes
FR2825921B1 (fr) * 2001-06-15 2005-02-11 Oreal Inhibiteur de no-synthase et utilisations
FR2850578B1 (fr) * 2003-02-03 2006-07-28 Oreal Utilisation de n-arylmethylene ethylenediaminetriacetates, n-arylmethyleneiminodiacetates ou n,n'-diarylmethylene ethylenediamineacetates comme donneurs de no
CA2456035A1 (fr) * 2003-02-03 2004-08-03 L'oreal Utilisation de n-arylmethylene ethylenediaminetriacetates, n-arylmethyleneiminodiacetates ou n,n'-diarylmethylene ethylenediamineacetates comme donneurs de no
CA2563207A1 (en) * 2004-04-14 2005-11-24 Celgene Corporation Use of selective cytokine inhibitory drugs in myelodysplastic syndromes
FR2939309B1 (fr) 2008-12-08 2010-12-17 Oreal Utilisation d'un derive ester de 2-pyrrolidinone 4-carboxy comme solvant dans les compositions cosmetiques ; compositions cosmetiques les contenant
FR2939651B1 (fr) * 2008-12-15 2011-01-14 Oreal Composition cosmetique associant un ester de l'acide n,n'-diarylmethylene ethylenediaminediacetique a un emulsionnant
US20100254922A1 (en) * 2008-12-15 2010-10-07 L'oreal Cosmetic and/or dermatological composition based on n,n'-diarylmethyleneethylenediaminediacetic acid ester(s)
FR2939653A1 (fr) * 2008-12-15 2010-06-18 Oreal Emulsion sous la forme d'oleosomes comprenant au moins un ester de l'acide n,n'-diarylmethylene ethylenediaminediacetique
FR2939650A1 (fr) * 2008-12-15 2010-06-18 Oreal Composition cosmetique et/ou dermatologique a base d'ester d'ester(s) de l'acide n,n'-diarylmethylene ethylenediaminediacetique
FR2939652A1 (fr) * 2008-12-15 2010-06-18 Oreal Emulsion cosmetique contenant un ester de l'acide n,n'- diarylmethylene ethylenediaminediacitique.
FR2940615B1 (fr) 2008-12-30 2011-12-30 Oreal Association de monosaccharides avec des agents antioxydants et son utilisation en cosmetique
FR2953714B1 (fr) * 2009-12-16 2011-11-25 Oreal Utilisation d'esters de l'acide n, n'-diarylmethylene ethylenediaminediacetique pour ameliorer la fonction barriere de la peau
JP5900968B2 (ja) 2011-01-14 2016-04-06 株式会社ダステック 高分子鉄キレート剤
FR2972346B1 (fr) 2011-03-09 2013-11-08 Oreal Utilisation d'un derive diester d'acide 2-methyl succinique comme solvant dans les compositions cosmetiques ; compositions cosmetiques les contenant
FR2996133B1 (fr) 2012-10-02 2015-06-26 Oreal Nouvelles utilisations cosmetiques de polymeres dispersants en association avec au moins un actif
JP7118591B2 (ja) 2017-02-28 2022-08-16 ロレアル レゾルシノール又はその誘導体を含む組成物
JP7412898B2 (ja) 2019-04-26 2024-01-15 ロレアル 特異な粒子と親油性抗酸化剤との組み合わせ
JP2021095354A (ja) 2019-12-16 2021-06-24 ロレアル 特定の成分の組合せを含む安定な組成物
WO2023120259A1 (en) 2021-12-20 2023-06-29 Oreal Stable composition comprising retinoid
WO2023120390A1 (en) 2021-12-20 2023-06-29 L'oreal Stable composition comprising retinoid and ascorbic acid compound
FR3131845A1 (fr) 2022-01-19 2023-07-21 L'oreal Composition stable comprenant un rétinoïde
FR3131837A1 (fr) 2022-01-19 2023-07-21 L'oreal Composition stable comprenant un rétinoïde et un composé acide ascorbique

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3886284A (en) * 1972-10-18 1975-05-27 Millmaster Onyx Corp Amino derivatives of terrasubstituted benzene compounds
DE2409355A1 (de) * 1974-02-27 1975-09-04 Hoechst Ag Thiatriazepinone sowie verfahren zu ihrer herstellung
SE7707198L (sv) * 1976-06-25 1977-12-26 Rohm & Haas Fosforhaltiga foreningar
CH602857A5 (de) * 1976-12-10 1978-08-15 Ciba Geigy Ag
US4448776A (en) * 1981-02-12 1984-05-15 Karl Bucher Method of using certain substituted aliphatic secondary amines or their salts for easing breathing
US4528196A (en) * 1981-02-23 1985-07-09 The United States Of America As Represented By The Department Of Health And Human Services Chelating agents for the treatment of iron overload
DE3825269C3 (de) * 1988-07-26 1994-09-01 Norbert Wagner Kurbelmechanismus für einen Hebe-Schiebedeckel eines Kraftfahrzeugs
NZ231180A (en) * 1988-10-31 1994-11-25 Dow Chemical Co Bifunctional chelants;complexes,conjugates and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
US5703095A (en) 1997-12-30
CA2149431A1 (fr) 1994-05-26
WO1994011338A1 (fr) 1994-05-26
JP3510627B2 (ja) 2004-03-29
ES2136723T3 (es) 1999-12-01
DE69326776D1 (de) 1999-11-18
JPH08506090A (ja) 1996-07-02
EP0668854A1 (de) 1995-08-30
EP0668854B1 (de) 1999-10-13
DE69326776T2 (de) 2000-03-02
US5629436A (en) 1997-05-13

Similar Documents

Publication Publication Date Title
ATE185548T1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
DE69326250D1 (de) Neuropeptide y antagoniste
NO307027B1 (no) Anvendelse av riluzol ved behandling av neurologiske lesjoner relatert til traumatiske skader
DE69531457D1 (en) Sulfonamide
DE69401204D1 (de) Gonadotropin enthaltende gefriergetrocknete troepfen
PT741716E (pt) Analogos de delta 12,13-iso-taxol sua utilizacao anti-neoplasica e composicoes farmaceuticas que os contem
HU9603042D0 (en) Use of certain methanebisphosphonic acid derivatives to prevent or for treatment of prosthesis loosening and prosthesis migration
ATE226436T1 (de) Neue verwendung von dexmedetomidin
FI972434A0 (fi) Lamotrigiiniä sisältävä farmaseuttinen koostumus
NZ240481A (en) Aminosulphonyl urea derivatives and pharmaceutical compositions
DK0561846T3 (da) 4,5-dihydroxy- og 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracencarboxylsyre-dicarbonater og -urethaner med terapeutisk virkning
TW261532B (de)
CZ157795A3 (en) Pharmaceutical preparations for treating prostatitis
DK0722325T3 (da) Præparat til behandling eller forebyggelse af herpes
GEP20032975B (en) Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition
GB9015774D0 (en) Novel treatment
FI952855A (fi) Uudet triatsolokinatsoliinit, niiden valmistus ja käyttö
AU4965693A (en) Optically active hydroquinine (amino-3 phenyl)-1 ethanesulfonate, preparation and use thereof
DE69428276D1 (de) Insulinähnlicher wachstumfaktor ii als antitumormittel

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee